Honokiol exhibited prominent antimetastatic activity in experimental osteosarcoma and caused rapid cell death in vitro that was unrelated to necrosis, apoptosis, or autophagy.
The authors concluded that honokiol has considerable potential for the treatment of metastasizing osteosarcoma.
2012-04-10
Eng.
Cancer
Laboratory for Orthopedic Research, Department of Orthopedics, University of Zurich, Switzerland.
Cancer. 2012 Apr;118(8):2117-27
© Galenicom 1999-2013